Search Results - "Gutierrez‐Valencia, Alicia"

Stepped-Dose Versus Full-Dose Efavirenz for HIV Infection and Neuropsychiatric Adverse Events: A Randomized Trial by GUTIERREZ-VALENCIA, Alicia, VICIANA, Pompeyo, PALACIOS, Rosario, RUIZ-VALDERAS, Rosa, LOZANO, Fernando, TERRON, Alberto, RIVERO, Antonio, LOPEZ-CORTES, Luis F

“…More than 50% of patients who start efavirenz treatment develop limiting neuropsychiatric adverse events (NPAEs). To assess whether stepwise dosing of…”
Get full text

Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations by Gutierrez‐Valencia, Alicia, Trujillo‐Rodriguez, Maria, Fernandez‐Magdaleno, Tamara, Espinosa, Nuria, Viciana, Pompeyo, López‐Cortés, Luis F

“…Introduction When darunavir (DRV) 800 mg is boosted with 150 mg cobicistat (DRVcobi), DRV trough concentration (Ctrough) is about 30% lower as compared to…”
Get full text

Intracellular and plasma pharmacokinetics of 400 mg of etravirine once daily versus 200 mg of etravirine twice daily in HIV-infected patients by Gutiérrez-Valencia, Alicia, Martin-Peña, Reyes, Torres-Cornejo, Almudena, Ruiz-Valderas, Rosa, Castillo-Ferrando, Juan R., López-Cortés, Luis F.

“…Objectives To compare intracellular and plasma etravirine concentrations when etravirine was given at 200 mg/12 h versus 400 mg/24 h and to evaluate whether…”
Get full text

Response to: Reply to: Anti-CD4 autoantibodies in immunological nonresponder people living with HIV: cause of CD4+ T cell depletion? by Muñoz-Muela, Esperanza, Ruiz-Mateos, Ezequiel, Gutiérrez-Valencia, Alicia, López-Cortés, Luis F.

Get full text

Association between Vancomycin Pharmacokinetic Parameters and Clinical and Microbiological Efficacy in a Cohort of Neonatal Patients by Mejías-Trueba, Marta, Alonso-Moreno, Marta, Gutiérrez-Valencia, Alicia, Herrera-Hidalgo, Laura, Guisado-Gil, Ana Belén, Jiménez-Parrilla, Francisco, Varela-Rubio, Elena, Gil-Navarro, Maria Victoria

“…Vancomycin pharmacokinetic/pharmacodynamic (PK/PD) targets have not been validated in the neonatal population as no specifically designed studies are…”
Get full text

Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients by López-Cortés, Luis F, Trujillo-Rodríguez, María, Báez-Palomo, Alicia, Benmarzouk-Hidalgo, Omar J, Dominguez-Molina, Beatriz, Milanés-Guisado, Yusnelkis, Espinosa, Nuria, Viciana, Pompeyo, Gutiérrez-Valencia, Alicia

“…There are contradictory data about the influence that hepatitis C virus (HCV) has on immune activation and inflammation in patients coinfected with human…”
Get full text

Immunological and inflammatory changes after simplifying to dual therapy in virologically suppressed HIV-infected patients through week 96 in a randomized trial by Trujillo-Rodríguez, María, Muñoz-Muela, Esperanza, Serna-Gallego, Ana, Milanés-Guisado, Yusnelkis, Praena-Fernández, Juan Manuel, Álvarez-Ríos, Ana Isabel, Herrera-Hidalgo, Laura, Domínguez, Montserrat, Lozano, Carmen, Romero-Vazquez, Gloria, Roca, Cristina, Espinosa, Nuria, Gutiérrez-Valencia, Alicia, López-Cortés, Luis F.

“…To evaluate whether simplification of antiretroviral treatment to dual therapy (DT) negatively impacts immune recovery (IR), immune activation and inflammation…”
Get full text

Anti-CD4 autoantibodies in immunological nonresponder people with HIV: cause of CD4 + T-cell depletion? by Muñoz-Muela, Esperanza, Trujillo-Rodríguez, María, Serna-Gallego, Ana, Ruiz-Mateos, Ezequiel, Espinosa, Nuria, Roca-Oporto, Critina, Benhnia, Mohamed Rafii-El-Idrissi, López-Cortés, Luis F., Gutiérrez-Valencia, Alicia

“…We aimed to evaluate the anti-CD4 IgG role in the poor immune recovery of immunological nonresponder people with HIV (INR). INR display low CD4 + T-cell…”
Get full text

Stability of temocillin in outpatient parenteral antimicrobial therapy: is it a real option? by Fernández-Rubio, Beatriz, Herrera-Hidalgo, Laura, López-Cortés, Luis E, Luque-Márquez, Rafael, De Alarcón, Arístides, Luque-Pardos, Sonia, Fernández-Polo, Aurora, Gutiérrez-Urbón, José María, Rodríguez-Baño, Jesús, Gil-Navarro, María Victoria, Gutiérrez-Valencia, Alicia

“…Abstract Background Temocillin is an interesting alternative to carbapenems for susceptible Enterobacteriaceae. Although its use in outpatient parenteral…”
Get full text

Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs? by Herrera-Hidalgo, Laura, de Alarcón, Arístides, López-Cortes, Luis Eduardo, Luque-Márquez, Rafael, López-Cortes, Luis Fernando, Gutiérrez-Valencia, Alicia, Gil-Navarro, María Victoria

“…Ceftriaxone administered as once-daily high-dose short infusion combined with ampicillin has been proposed for the treatment of infective endocarditis in…”
Get full text

Response to a reinforced hepatitis B vaccination scheme in HIV-infected patients under real-life conditions by Neukam, Karin, Gutiérrez-Valencia, Alicia, Llaves-Flores, Silvia, Espinosa, Nuria, Viciana, Pompeyo, López-Cortés, Luis F.

“…•HIV infected patients are at high risk of hepatitis B virus infection.•Response to standard hepatitis B virus vaccine is suboptimal low in…”
Get full text

Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients? by Milanés-Guisado, Yusnelkis, Gutiérrez-Valencia, Alicia, Muñoz-Pichardo, Juan Manuel, Rivero, Antonio, Trujillo-Rodriguez, Maria, Ruiz-Mateos, Ezequiel, Espinosa, Nuria, Roca-Oporto, Cristina, Viciana, Pompeyo, López-Cortés, Luis F

“…Abstract Objectives To analyse whether integrase inhibitor (InSTI)-based regimens achieve better immunological recovery than NNRTI- or boosted PI (bPI)-based…”
Get full text

HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. maintaining triple therapy based on integrase inhibitors by Muñoz-Muela, Esperanza, Trujillo-Rodríguez, María, Serna-Gallego, Ana, Saborido-Alconchel, Abraham, Ruiz-Mateos, Ezequiel, López-Cortés, Luis F., Gutiérrez-Valencia, Alicia

“…Dual therapy (DT) has shown comparable results to triple therapy (TT) in efficacy and other immunological aspects. However, there are still some concerns about…”
Get full text

SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance? by Guisado Hernández, Paloma, Blanco Lobo, Pilar, Villaoslada, Isabel, de Felipe, Beatriz, Lucena, José M., Martín Gutierrez, Guillermo, Castro, María José, Gutiérrez Valencia, Alicia, Sánchez Codez, María Isabel, Gaboli, Mirella, Neth, Olaf, Olbrich, Peter

Get full text

Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes by Ceperuelo-Mallafré, Victòria, Reverté, Laia, Peraire, Joaquim, Madeira, Ana, Maymó-Masip, Elsa, López-Dupla, Miguel, Gutierrez-Valencia, Alicia, Ruiz-Mateos, Ezequiel, Buzón, Maria José, Jorba, Rosa, Vendrell, Joan, Auguet, Teresa, Olona, Montserrat, Vidal, Francesc, Rull, Anna, Fernández-Veledo, Sonia

“…Coronavirus-19 (COVID-19) disease is driven by an unchecked immune response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus which…”
Get full text

Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors by Saborido-Alconchel, Abraham, Serna-Gallego, Ana, Trujillo-Rodriguez, María, Muñoz-Muela, Esperanza, Álvarez-Ríos, Ana I, Lozano, Carmen, Llaves-Flores, Silvia, Espinosa, Nuria, Roca-Oporto, Cristina, Herrero, Marta, Sotomayor, Cesar, Gutierrez-Valencia, Alicia, Lopez-Cortes, Luis F

“…To compare the long-term effects on immune parameters, inflammation, and HIV-1 reservoir after switching to a two-drug (2DR) versus maintaining an integrase…”
Get full text

Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients by Trujillo-Rodriguez, María, Muñoz-Muela, Esperanza, Serna-Gallego, Ana, Praena-Fernández, Juan Manuel, Pérez-Gómez, Alberto, Gasca-Capote, Carmen, Vitallé, Joana, Peraire, Joaquim, Palacios-Baena, Zaira R, Cabrera, Jorge Julio, Ruiz-Mateos, Ezequiel, Poveda, Eva, López-Cortés, Luis Eduardo, Rull, Anna, Gutierrez-Valencia, Alicia, López-Cortés, Luis Fernando

“…Background The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its severity in a high percentage of cases…”
Get full text

Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients by MIRA, Jasé A, VALERA-BESTARD, Barbara, LOPEZ-CORTES, Luis F, PINEDA, Juan A, ARIZCORRETA -YARZA, Ana, GONZALEZ-SERRANO, Mercedes, TORRE-CISNEROS, Julian, SANTOS, Ignacio, VERGARA, Salvador, GUTIERREZ -VALENCIA, Alicia, GIRON-GONZALEZ, José A, MACIAS, Juan

“…The clinical applicability of early viral kinetics at week 4 in predicting sustained virological response (SVR) of pegylated interferon (peg-IFN) plus…”
Get full text

Absolute CD4+ T cell count overstate immune recovery assessed by CD4+/CD8+ ratio in HIV-infected patients on treatment by Milanés-Guisado, Yusnelkis, Gutiérrez-Valencia, Alicia, Trujillo-Rodríguez, María, Espinosa, Nuria, Viciana, Pompeyo, López-Cortés, Luis Fernando

“…To analyse the correlation and concordance between aCD4, CD4%, CD4/CD8, their intra-patient variability, and to compare the immune recovery (IR) rates based on…”
Get full text

Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life by Mejías-Trueba, Marta, Gutierrez-Valencia, Alicia, Llaves-Flores, Silvia, Roca-Oporto, Cristina, Herrero, Marta, Sotomayor de la Piedra, César, Lopez-Cortes, Luis F, Espinosa, Nuria

“…Real-life data on doravirine (DOR) in different drug combinations are limited. We evaluated the effectiveness of DOR plus two nucleos(t)ide reverse…”
Get full text